Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Rank in Stocks #26003
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Share Price
$10.04
Last synced: 2023-05-05
Market Cap
$44.29M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Eucrates Biomedical Acquisition Corp. (EUCR)
Earnings for Eucrates Biomedical Acquisition Corp. (EUCR)
Earnings in 2026 TTM: 0
According to Eucrates Biomedical Acquisition Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Eucrates Biomedical Acquisition Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors